CERE: Cerevel Therapeutics (CERE) and AbbVie (ABBV) following discussions with the FTC, voluntarily withdrew the initial HSR Act notification and refiled a new HSR Act notification. The waiting period under the HSR Act is set to expire on February 16, 2024.
IRBT: According to The Wall Street Journal, the European Union’s competition watchdog intends to block Amazon’s (AMZN) bid to purchase iRobot (IRBT).
You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.
Only plus or premium subscribers can access this post. Subscribe today.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok